BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Philips launches ultra lightweight and flexible MR Smart Fit coils to improve radiology productivity and diagnostic confidence at #RSNA23

  RoyalPhilips, a global leader in health technology, launched three new fit for purpose MR Smart Fit coils at #RSNA23.

  November 28, 2023

   · 

  2 min read
• BioMidwest

  Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium

  Sermonix Pharmaceuticals Inc. today announced that it had five abstracts accepted as poster presentations at the 2023 San Antonio Breast Cancer Symposium (SABCS), which will be held Dec. 5-9 at the Henry B. Gonzalez Convention Center in San Antonio.

  November 28, 2023

   · 

  5 min read
• Genetown

  Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences

  Thermo Fisher Scientific Inc., the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an accelerated basis.

  November 28, 2023

   · 

  3 min read
• Drug Development

  Ambrx Provides Update On APEX-01, an On-Going Phase 1 / 2 Dose Escalation Study Evaluating ARX517, a Proprietary PSMA-Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

  Ambrx Biopharma today announced a clinical update regarding its proprietary anti-PSMA antibody drug conjugate (ADC) ARX517 in the ongoing APEX-01 Phase 1 / 2 dose escalation and dose expansion clinical trial in metastatic castration-resistant prostate cancer (mCRPC).

  November 28, 2023

   · 

  5 min read
• BioForest

  Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023

  Kineta, Inc. announced today that it will host a virtual KOL event to discuss new data from the VISTA-101 clinical trial of KVA12123 in patients with advanced solid tumors.

  November 28, 2023

   · 

  7 min read
• Lone Star Bio

  Monogram Orthopaedics Delivers First Surgical Robot

  Monogram Orthopaedics Inc. has delivered its first surgical robot to one of the world’s largest global robotics distributors.

  November 28, 2023

   · 

  3 min read